Top Sleep Apnea Devices Companies

Global Sleep Apnea Devices Market size was valued at USD 5.40 Billion in 2024 and is poised to grow from USD 5.8 Billion in 2025 to USD 10.2 Billion by 2033, growing at a CAGR of 7.32% during the forecast period (2026–2033).

The global sleep apnea devices market is notably progressing backed by constant efforts by several global competitors. The leading market vendors focused on offering portable devices and user-friendly designs comprise Koninklijke Philips N.V., SomnoMed, Oventus Medical, Fisher & Paykel Healthcare Limited, and Braebon Medical Corporation. These industry experts are highly focused on developing custom-fit oral devices and wearable technologies to help treat different sleep disorders prevalent on global scale. Overall, the global market is fueled by the growing elderly population, emergence of innovative solutions like improvements in CPAP devices, and awareness for sleep disorders. 'ResMed (United States)', 'Koninklijke Philips N.V. (Netherlands) ', 'Fisher & Paykel Healthcare Limited (New Zealand) ', 'Inspire Medical Systems, Inc. (United States) ', 'SomnoMed (Australia) ', 'Oventus Medical (Australia) ', 'Compumedics Limited (Australia) ', 'Lowenstein Medical Technology GmbH + Co. KG (Germany) ', 'BMC Medical Co., Ltd. (China) ', 'Braebon Medical Corporation (Canada) ', 'Whole You, Inc. (United States) ', 'Panthera Dental (Canada) ', 'Myerson LLC (United States) ', 'ProSomnus Sleep Technologies (United States) ', 'Nidek Medical India (India) ', 'TOMED GmbH (Germany) ', 'LivaNova (United Kingdom) ', 'Invacare Corporation (United States) ', 'MPowrx Health & Wellness (Canada)'

The growing inclination towards home-based care like HSAT (home sleep apnea testing) is enabling patients to perform tests in a more comfortable and in a convenient manner. This increases treatment initiation and increased diagnosis. Moreover, the growing shift towards using homecare therapies like CPAP due to their easy use and flexibility as compared to in-lab testing is driving their demand and hence, the sleep apnea devices market growth.

Remote Monitoring and Telehealth: The recent pandemic has considerably increased the use and adoption of telehealth, enabling individuals to contact and take advice from their medical professionals virtually. This trend continues to progress and allows remote monitoring and modifications in therapy. Patients are also actively preferring home-based testing devices that reduce frequent lab visits.

Region-wise, North America sleep apnea devices market share dominated the market in 2023 and is expected to lead over the forecast period owing to the growing incidences of sleep disorders, the presence of improved healthcare, and increased education and awareness among individuals for sleep apnea and benefits of its treatments. North America holds the leading number of patients suffering from sleep apnea, which ultimately demands reliable and effective therapies and treatments. Also, the growing obesity cases and sedentary lifestyles is associated with sleep disorders, thus demanding better treatments. Regional growth is also impacted by the availability of developed healthcare systems and better accessibility to streamline treatment and diagnostics. The leading players profiled in the region include Philips Respironics, Medtronic, SomnoMed, ResMed Inc., Natus Medical Incorporated, Oventus Medical, Breas Medical, and more.